US Patent 8431578 Organic compounds
Patent 8431578 was granted and assigned to Novartis on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+433 characters)
Article
Patent abstract
Compounds of formula (I) in free or salt or solvate form, where T1, T2, and T3 have the meanings as indicated in the specification, are useful for treating inflammatory or obstructive airways, pulmonary hypertension, pulmonary fibrosis, liver fibrosis, muscle diseases and systemic skeletal disorders. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Catherine Leblanc0
Nikolaus Johannes Stiefl0
Peter Hunt0
Robert Alexander Pulz0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08431578 Organic compounds US Patent 8431578 Organic compounds
Infobox
Patent Number
084315780
Patent Number
84315780
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084315780
Date of Patent
April 30, 2013
0Patent Application Number
128109480
Date Filed
January 9, 2009
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08431578 Organic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08431578
Date of patent
April 30, 2013
Patent application number
12810948
Date Filed
January 9, 2009
Patent primary examiner
Find more entities like US Patent 8431578 Organic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
